Induced Sputum, Exhaled Nitric Oxide, and Particles in Exhaled Air in Assessing Airways Inflammation in Occupational Exposures

Clinics in Chest Medicine

Volumn 33, Issue 4, 2012, Pages 771-782

  Olin, Anna Carin ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Exhaled nitric oxide; Exhaled particles; Induced sputum; Occupational exposure

Indexed keywords

ALLERGEN; ENDOTOXIN; IRRITANT AGENT; NITRIC OXIDE;

AMBIENT AIR; BRONCHITIS; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; EXPIRED AIR; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INHALATION TEST; MOLECULAR WEIGHT; NONHUMAN; OCCUPATIONAL ASTHMA; OCCUPATIONAL DISEASE; OCCUPATIONAL EOSINOPHILIC BRONCHITIS; OCCUPATIONAL EXPOSURE; PATHOPHYSIOLOGY; PEAK EXPIRATORY FLOW; PH MEASUREMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT INFLAMMATION; REVIEW; SENSITIVITY ANALYSIS; SPUTUM EXAMINATION;

EXHALATION; HUMANS; INFLAMMATION; NITRIC OXIDE; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PARTICULATE MATTER; RESPIRATORY TRACT DISEASES; SPUTUM;

EID: 84869208026     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2012.08.002     Document Type: Review

References (86)

1. Berry M.A., Shaw D.E., Green R.H., et al. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin Exp Allergy 2005, 35(9):1175-1179.
2. Manso L., Madero M.F., Ruiz-Garcia M., et al. Comparison of bronchial hyperresponsiveness to methacholine and adenosine and airway inflammation markers in patients with suspected asthma. J Asthma 2011, 48(4):335-340.
3. Prince P., Lemiere C., Dufour M.H., et al. Airway inflammatory responses following exposure to occupational agents. Chest 2012, 141(6):1522-1527.
4. Quirce S., Lemiere C., de Blay F., et al. Noninvasive methods for assessment of airway inflammation in occupational settings. Allergy 2010, 65(4):445-458.
5. Gautrin D., Malo J.L. Risk factors, predictors, and markers for work-related asthma and rhinitis. Curr Allergy Asthma Rep 2010, 10(5):365-372.
6. Green R.H., Brightling C.E., McKenna S., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002, 360(9347):1715-1721.
7. Wenzel S.E. Asthma: defining of the persistent adult phenotypes. Lancet 2006, 368(9537):804-813.
8. Baines K.J., Simpson J.L., Wood L.G., et al. Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. J Allergy Clin Immunol 2011, 127(1):153-160.
9. Haldar P., Pavord I.D., Shaw D.E., et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008, 178(3):218-224.
10. Malo J.L., Cardinal S., Ghezzo H., et al. Association of bronchial reactivity to occupational agents with methacholine reactivity, sputum cells and immunoglobulin E-mediated reactivity. Clin Exp Allergy 2011, 41(4):497-504.
11. Fernandez-Nieto M., Sastre B., Sastre J., et al. Changes in sputum eicosanoids and inflammatory markers after inhalation challenges with occupational agents. Chest 2009, 136(5):1308-1315.
12. Sundblad B.M., von Scheele I., Palmberg L., et al. Repeated exposure to organic material alters inflammatory and physiological airway responses. Eur Respir J 2009, 34(1):80-88.
13. Holz O., Richter K., Jorres R.A., et al. Changes in sputum composition between two inductions performed on consecutive days. Thorax 1998, 53(2):83-86.
14. Vandenplas O., D'Alpaos V., Heymans J., et al. Sputum eosinophilia: an early marker of bronchial response to occupational agents. Allergy 2009, 64(5):754-761.
15. Hur G.Y., Sheen S.S., Kang Y.M., et al. Histamine release and inflammatory cell infiltration in airway mucosa in methylene diphenyl diisocyanate (MDI)-induced occupational asthma. J Clin Immunol 2008, 28(5):571-580.
16. Moreira A., Palmares C., Lopes C., et al. Airway vascular damage in elite swimmers. Respir Med 2011, 105(11):1761-1765.
17. Lemiere C., Chaboillez S., Welman M., et al. Outcome of occupational asthma after removal from exposure: a follow-up study. Can Respir J 2010, 17(2):61-66.
18. Brightling C.E. Cough due to asthma and nonasthmatic eosinophilic bronchitis. Lung 2010, 188(Suppl 1):S13-S17.
19. Pala G., Pignatti P., Moscato G. Occupational nonasthmatic eosinophilic bronchitis: current concepts. Med Lav 2012, 103(1):17-25.
20. Ferrazzoni S., Scarpa M.C., Guarnieri G., et al. Exhaled nitric oxide and breath condensate ph in asthmatic reactions induced by isocyanates. Chest 2009, 136(1):155-162.
21. Dahgam S., Nyberg F., Modig L., et al. Single nucleotide polymorphisms in the NOS2 and NOS3 genes are associated with exhaled nitric oxide. J Med Genet 2012, 49(3):200-205.
22. Barbinova L., Baur X. Increase in exhaled nitric oxide (eNO) after work-related isocyanate exposure. Int Arch Occup Environ Health 2006, 79(5):387-395.
23. Smit L.A., Heederik D., Doekes G., et al. Exhaled nitric oxide in endotoxin-exposed adults: effect modification by smoking and atopy. Occup Environ Med 2009, 66(4):251-255.
24. Rouhos A., Kainu A., Piirila P., et al. Repeatability of exhaled nitric oxide measurements in patients with COPD. Clin Physiol Funct Imaging 2011, 31(1):26-31.
25. Malinovschi A., Backer V., Harving H., et al. The value of exhaled nitric oxide to identify asthma in smoking patients with asthma-like symptoms. Respir Med 2012, 106(6):794-801.
26. de Gouw H.W., Hendriks J., Woltman A.M., et al. Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma. Am J Respir Crit Care Med 1998, 158(1):315-319.
27. Ho L.P., Wood F.T., Robson A., et al. Atopy influences exhaled nitric oxide levels in adult asthmatics. Chest 2000, 118(5):1327-1331.
28. Deykin A., Massaro A.F., Coulston E., et al. Exhaled nitric oxide following repeated spirometry or repeated plethysmography in healthy individuals. Am J Respir Crit Care Med 2000, 161(4 Pt 1):1237-1240.
29. Adisesh L.A., Kharitonov S.A., Yates D.H., et al. Exhaled and nasal nitric oxide is increased in laboratory animal allergy. Clin Exp Allergy 1998, 28(7):876-880.
30. Hewitt R.S., Smith A.D., Cowan J.O., et al. Serial exhaled nitric oxide measurements in the assessment of laboratory animal allergy. J Asthma 2008, 45(2):101-107.
31. Chan-Yeung M., Obata H., Dittrick M., et al. Airway inflammation, exhaled nitric oxide, and severity of asthma in patients with western red cedar asthma. Am J Respir Crit Care Med 1999, 159(5 Pt 1):1434-1438.
32. Obata H., Dittrick M., Chan H., et al. Sputum eosinophils and exhaled nitric oxide during late asthmatic reaction in patients with western red cedar asthma. Eur Respir J 1999, 13(3):489-495.
33. Tan K., Bruce C., Birkhead A., et al. Nasal and exhaled nitric oxide in response to occupational latex exposure. Allergy 2001, 56(7):627-632.
34. Allmers H., Chen Z., Barbinova L., et al. Challenge from methacholine, natural rubber latex, or 4,4- diphenylmethane diisocyanate in workers with suspected sensitization affects exhaled nitric oxide change in exhaled NO levels after allergen challenges. Int Arch Occup Environ Health 2000, 73(3):181-186.
35. Shiryaeva O., Aasmoe L., Straume B., et al. Respiratory impairment in Norwegian salmon industry workers: a cross-sectional study. J Occup Environ Med 2010, 52(12):1167-1172.
36. Shiryaeva O., Aasmoe L., Straume B., et al. An analysis of the respiratory health status among seafarers in the Russian trawler and merchant fleets. Am J Ind Med 2011, 54(12):971-979.
37. van der Walt A., Lopata A.L., Nieuwenhuizen N.E., et al. Work-related allergy and asthma in spice mill workers-the impact of processing dried spices on IgE reactivity patterns. Int Arch Allergy Immunol 2010, 152(3):271-278.
38. Tossa P., Paris C., Zmirou-Navier D., et al. Increase in exhaled nitric oxide is associated with bronchial hyperresponsiveness among apprentices. Am J Respir Crit Care Med 2010, 182(6):738-744.
39. Lund M.B., Oksne P.I., Hamre R., et al. Increased nitric oxide in exhaled air: an early marker of asthma in non-smoking aluminium potroom workers?. Occup Environ Med 2000, 57(4):274-278.
40. Ulvestad B., Lund M.B., Bakke B., et al. Gas and dust exposure in underground construction is associated with signs of airway inflammation. Eur Respir J 2001, 17(3):416-421.
41. Olin A.C., Ljungkvist G., Bake B., et al. Exhaled nitric oxide among pulpmill workers reporting gassing incidents involving ozone and chlorine dioxide. Eur Respir J 1999, 14(4):828-831.
42. Olin A.C., Andersson E., Andersson M., et al. Prevalence of asthma and exhaled nitric oxide are increased in bleachery workers exposed to ozone. Eur Respir J 2004, 23(1):87-92.
43. Pronk A., Preller L., Doekes G., et al. Different respiratory phenotypes are associated with isocyanate exposure in spray painters. Eur Respir J 2009, 33(3):494-501.
44. Sue-Chu M., Henriksen A.H., Bjermer L. Non-invasive evaluation of lower airway inflammation in hyper-responsive elite cross-country skiers and asthmatics. Respir Med 1999, 93(10):719-725.
45. Demange V., Bohadana A., Massin N., et al. Exhaled nitric oxide and airway hyperresponsiveness in workers: a preliminary study in lifeguards. BMC Pulm Med 2009, 9:53.
46. Sastre J., Madero M.F., Fernandez-Nieto M., et al. Airway response to chlorine inhalation (bleach) among cleaning workers with and without bronchial hyperresponsiveness. Am J Ind Med 2011, 54(4):293-299.
47. Fell A.K., Noto H., Skogstad M., et al. A cross-shift study of lung function, exhaled nitric oxide and inflammatory markers in blood in Norwegian cement production workers. Occup Environ Med 2011, 68(11):799-805.
48. Carlsten C., de Roos A.J., Kaufman J.D., et al. Cell markers, cytokines, and immune parameters in cement mason apprentices. Arthritis Rheum 2007, 57(1):147-153.
49. Mauer M.P., Hoen R., Jourd'heuil D. FE NO concentrations in World Trade Center responders and controls, 6 years post-9/11. Lung 2011, 189(4):295-303.
50. Piirila P., Wikman H., Luukkonen R., et al. Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics 2001, 11(5):437-445.
51. Von Essen S.G., Scheppers L.A., Robbins R.A., et al. Respiratory tract inflammation in swine confinement workers studied using induced sputum and exhaled nitric oxide. J Toxicol Clin Toxicol 1998, 36(6):557-565.
52. Kolbeck K.G., Ehnhage A., Juto J.E., et al. Airway reactivity and exhaled NO following swine dust exposure in healthy volunteers. Respir Med 2000, 94(11):1065-1072.
53. Sundblad B.M., Larsson B.M., Palmberg L., et al. Exhaled nitric oxide and bronchial responsiveness in healthy subjects exposed to organic dust. Eur Respir J 2002, 20(2):426-431.
54. Hiel D., von Scheele I., Sundblad B.M., et al. Evaluation of respiratory effects related to high-pressure cleaning in a piggery with and without robot pre-cleaning. Scand J Work Environ Health 2009, 35(5):376-383.
55. Heldal K.K., Madso L., Huser P.O., et al. Exposure, symptoms and airway inflammation among sewage workers. Ann Agric Environ Med 2010, 17(2):263-268.
56. Purokivi M., Hirvonen M.R., Randell J., et al. Nitric oxide alone is an insufficient biomarker of exposure to microbes in a moisture-damaged building. Inhal Toxicol 2002, 14(12):1279-1290.
57. Roponen M., Kiviranta J., Seuri M., et al. Inflammatory mediators in nasal lavage, induced sputum and serum of employees with rheumatic and respiratory disorders. Eur Respir J 2001, 18(3):542-548.
58. Akpinar-Elci M., Siegel P.D., Cox-Ganser J.M., et al. Respiratory inflammatory responses among occupants of a water-damaged office building. Indoor Air 2008, 18(2):125-130.
59. Franklin P., Dingle P., Stick S. Raised exhaled nitric oxide in healthy children is associated with domestic formaldehyde levels. Am J Respir Crit Care Med 2000, 161(5):1757-1759.
60. Simpson A., Custovic A., Pipis S., et al. Exhaled nitric oxide, sensitization, and exposure to allergens in patients with asthma who are not taking inhaled steroids. Am J Respir Crit Care Med 1999, 160(1):45-49.
61. Langley S.J., Goldthorpe S., Craven M., et al. Exposure and sensitization to indoor allergens: association with lung function, bronchial reactivity, and exhaled nitric oxide measures in asthma. J Allergy Clin Immunol 2003, 112(2):362-368.
62. Moore V.C., Anees W., Jaakkola M.S., et al. Two variants of occupational asthma separable by exhaled breath nitric oxide level. Respir Med 2010, 104(6):873-879.
63. Lehtimaki L., Kankaanranta H., Saarelainen S., et al. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med 2001, 163(7):1557-1561.
64. Tsoukias N.M., George S.C. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 1998, 85(2):653-666.
65. Verbanck S., Malinovschi A., George S., et al. Bronchial and alveolar components of exhaled nitric oxide and their relationship. Eur Respir J 2012, 39(5):1258-1261.
66. Lehtimaki L., Oksa P., Jarvenpaa R., et al. Pulmonary inflammation in asbestos-exposed subjects with borderline parenchymal changes on HRCT. Respir Med 2010, 104(7):1042-1049.
67. Sauni R., Oksa P., Lehtimaki L., et al. Increased alveolar nitric oxide and systemic inflammation markers in silica-exposed workers. Occup Environ Med 2012, 69(4):256-260.
68. Lemiere C., D'Alpaos V., Chaboillez S., et al. Investigation of occupational asthma: sputum cell counts or exhaled nitric oxide?. Chest 2010, 137(3):617-622.
69. Swierczynska-Machura D., Krakowiak A., Wiszniewska M., et al. Exhaled nitric oxide levels after specific inahalatory challenge test in subjects with diagnosed occupational asthma. Int J Occup Med Environ Health 2008, 21(3):219-225.
70. Rosias P.P., Robroeks C.M., Niemarkt H.J., et al. Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate. Eur Respir J 2006, 28(5):1036-1041.
71. Gessner C., Kuhn H., Seyfarth H.J., et al. Factors influencing breath condensate volume. Pneumologie 2001, 55(9):414-419.
72. Effros R.M., Biller J., Foss B., et al. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med 2003, 168(12):1500-1505.
73. Zetterquist W., Marteus H., Kalm-Stephens P., et al. Oral bacteria- the missing link to ambiguous findings of exhaled nitrogen oxides in cystic fibrosis. Respir Med 2009, 103:187-193.
74. Koczulla A.R., Noeske S., Herr C., et al. Acute and chronic effects of smoking on inflammation markers in exhaled breath condensate in current smokers. Respiration 2010, 79(1):61-67.
75. Koczulla R., Dragonieri S., Schot R., et al. Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients. Respir Res 2009, 10:78.
76. Effros R.M. Do low exhaled condensate NH4+ concentrations in asthma reflect reduced pulmonary production?. Am J Respir Crit Care Med 2003, 167(1):91. [author reply: 91-2].
77. Wells K., Vaughan J., Pajewski T.N., et al. Exhaled breath condensate pH assays are not influenced by oral ammonia. Thorax 2005, 60(1):27-31.
78. Kullmann T., Barta I., Lazar Z., et al. Exhaled breath condensate pH standardised for CO2 partial pressure. Eur Respir J 2007, 29(3):496-501.
79. Almstrand A.C., Ljungstrom E., Lausmaa J., et al. Airway monitoring by collection and mass spectrometric analysis of exhaled particles. Anal Chem 2009, 81(2):662-668.
80. Larsson P., Mirgorodskaya E., Samuelsson L., et al. Surfactant protein A and albumin in particles in exhaled air. Respir Med 2012, 106(2):197-204.
81. Bredberg A., Gobom J., Almstrand A.C., et al. Exhaled endogenous particles contain lung proteins. Clin Chem 2012, 58(2):431-440.
82. Almstrand A.C., Josefson M., Bredberg A., et al. TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls. Eur Respir J 2012, 39(1):59-66.
83. Holmgren H., Ljungström E., Almstrand A.C., et al. Size distribution of exhaled particles in the range from 0.01 to 2.0 μm. J Aerosol Sci 2010, 41:439-446.
84. Lemiere C., Chaboilliez S., Trudeau C., et al. Characterization of airway inflammation after repeated exposures to occupational agents. J Allergy Clin Immunol 2000, 106(6):1163-1170.
85. Fireman E., Lerman Y., Stark M., et al. Detection of occult lung impairment in welders by induced sputum particles and breath oxidation. Am J Ind Med 2008, 51(7):503-511.
86. Fireman E.M., Lerman Y., Ben Mahor M., et al. Redefining idiopathic interstitial lung disease into occupational lung diseases by analysis of chemical composition of inhaled dust particles in induced sputum and/or lung biopsy specimens. Toxicol Ind Health 2007, 23(10):607-615.